TrialInternational journal of clinical oncology2015

Effect of TU-100, a traditional Japanese medicine, administered after hepatic resection in patients with liver cancer: a multi-center, phase III trial (JFMC40-1001).

Mitsuo Shimada et al.PubMed ↗Publisher ↗

No numbers read from the abstract.